Aspira Women's Health Inc. of AUSTIN, TX filed a DEFR14A with the SEC on 2025-04-22. Industry: In Vitro & In Vivo Diagnostic Substances.
| Seq | Type | Description |
|---|---|---|
| 1 | DEFR14A | formdefr14a.htm |
| 2 | GRAPHIC | proxy_001.jpg |
| 3 | GRAPHIC | proxy_002.jpg |
| 4 | EX-101.SCH | XBRL SCHEMA FILE |
| 5 | EX-101.DEF | XBRL DEFINITION FILE |
| 6 | EX-101.LAB | XBRL LABEL FILE |
| 7 | EX-101.PRE | XBRL PRESENTATION FILE |
| 23 | XML | EXTRACTED XBRL INSTANCE DOCUMENT |
Showing 12 of 60 filings.
| Filed | Form |
|---|---|
| 2026-05-29 | DEFA14A |
| 2026-04-28 | DEFA14A |
| 2026-04-24 | DEF 14A |
| 2025-04-22 | DEFR14A |
| 2025-04-11 | DEF 14A |
| 2025-03-31 | PRE 14A |
| 2024-05-10 | DEFA14A |
| 2024-04-01 | DEFA14A |
| 2024-04-01 | DEF 14A |
| 2023-04-04 | DEFA14A |
| 2023-03-30 | DEF 14A |
| 2023-03-20 | PRE 14A |